Skip to main content

Patient selection & referral

Recommending the right patients for Enterra® Therapy

Enterra Therapy, the only device designed to reduce nausea and vomiting symptoms associated with gastroparesis, may be appropriate for patients who:

  • Have gastroparesis caused by diabetic or idiopathic origin
  • Have difficulty managing nausea and vomiting symptoms, despite having tried first-line therapies of diet modification and medications
  • Are 18-70 of age
Download screening & referral form

Referring your gastroparesis patients to an implanting physician is a 3-STEP process.

STEP 1: Educate
STEP 2: Recommend
STEP 3: Refer

STEP 1

Educate

Educate your patients about gastroparesis symptoms, diagnosis, and treatment options.

See all patient education resources

Use this video to educate patients about gastroparesis and Enterra Therapy

Watch video

STEP 2

Recommend

If you think your patient may be a candidate for GES, recommend that they consult with a specialist.

Download screening & referral form
Consider the patient care pathway and full patient selection criteria for your gastroparesis patients when recommending Enterra Therapy:
View patient care pathway

STEP 3

Refer

Complete the referral form to send your patient to a trained Enterra implanter or GI specialist.

Find an Enterra implanter

If you have a patient who may be a candidate for receiving Enterra Therapy, use this tool to find a trained implanter or GI specialist in your area.

NEXT: Contact a rep

MKT-D-0006, Rev S

IMPORTANT SAFETY INFORMATION

Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.

HUMANITARIAN DEVICE

Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?